The firm shows a Beta (market volatility) of 0.2318, which signifies not very significant fluctuations relative to the market. Let's try to break down what Applied's beta means in this case. As returns on the market increase, Applied Dna returns are expected to increase less than the market. However, during the bear market, the loss on holding Applied Dna will be expected to be smaller as well. Even though it is essential to pay attention to
Applied Dna Scns historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's
future performance is to check both, its past performance charts as well as the business as a whole, including all available
technical indicators. Applied Dna Scns exposes twenty-eight different technical indicators, which can help you to evaluate its performance.
Applied Dna Scns has an expected return of -0.0792%. Please be advised to confirm Applied Dna Scns
sortino ratio,
skewness,
price action indicator, as well as the
relationship between the
potential upside and
rate of daily change to decide if
Applied Dna Scns performance from the past will be repeated at some point in the near future.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Applied DNA income statement, its balance sheet, and the statement of cash flows. Potential Applied DNA investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Applied DNA investors may use each financial statement separately, they are all related. The changes in Applied DNA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Applied DNA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of Applied DNA
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Applied DNA performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Applied DNA shares is the value that is considered the true value of the share. If
the intrinsic value of Applied is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Applied DNA. Please read more on our
fundamental analysis page.
How effective is Applied DNA in utilizing its assets?
Applied DNA Sciences reports assets on its Balance Sheet. It represents the amount of Applied resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, Applied DNA aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Electronic Equipment, Instruments & Components space. To get a better handle on how balance sheet or income statements item affect Applied volatility, please check the breakdown of all its
fundamentals.
Are Applied DNA Earnings Expected to grow?
The
future earnings power of Applied DNA involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Applied DNA factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Applied DNA
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Applied
expected earnings.
Applied DNA Gross Profit
Applied DNA Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Applied DNA previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Applied DNA Gross Profit growth over the last 10 years. Please check Applied DNA's
gross profit and other
fundamental indicators for more details.
Is Applied DNA valued appropriately by the market?
The entity reported the previous year's revenue of 6.3
M. Net Loss for the year was (13.9
M) with profit before overhead, payroll, taxes, and interest of 1.21
M.
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Applied Dna has an asset utilization ratio of 40.47 percent. This suggests that the company is making $0.4 for each dollar of assets. An increasing asset utilization means that Applied Dna Scns is more efficient with each dollar of assets it utilizes for everyday operations.
| Current Assets | 8.86 Million | 71.3 |
| Assets Non Current | 2.44 Million | 19.65 |
| Goodwill | 1.12 Million | 9.06 |
Our Applied analysis suggests possible reversion in January
Latest market risk adjusted performance is at -0.42. Applied Dna Scns exhibits very low volatility with skewness of 2.43 and kurtosis of 9.35. However, we advise investors to further study Applied Dna Scns technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Applied Dna's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Applied Dna's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Applied Dna Implied Volatility
Applied Dna's implied volatility exposes the market's sentiment of Applied Dna Scns stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Applied Dna's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Applied Dna stock will not fluctuate a lot when Applied Dna's options are near their expiration.
Whereas many other companies in the diagnostics & research industry are either recovering or due for a correction, Applied Dna may not be performing as strong as the other in terms of long-term growth potentials. With a relatively neutral outlook on the latest economy, it is better to hold off any trading of Applied as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Applied Dna.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Gabriel Shpitalnik is a Member of Macroaxis Editorial Board. Gabriel is a young entrepreneur and writes predominantly on the business, technology, and finance sector. He likes to analyze different equity instruments across a wide range of industries focusing primarily on consumer products and evolving technologies.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Applied DNA Sciences. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com